Skip to main content
. 2020 Apr 16;9(8):827–838. doi: 10.1002/sctm.19-0409

TABLE 3.

Net change of deterioration from baseline to month 12

Variables Study group Control group P value
Ccr, mL/min −4.58 ± 7.03 −3.02 ± 8.75 .446
BUN, mg/dL 3.96 ± 8.59 1.28 ± 9.25 .339
Creatinine, mg/dL

0.37 ± 0.43

0.34 (−0.02, 0.57)

0.51 ± 1.46

0.08 (−0.09, 0.42)

.269
Ratio of uTP to uCre, mg/g

841.7 ± 2176.4

7.1 (−39.7, 1038.2)

−167.9 ± 748.2

−11.8 (−277.3, 45.2)

.178
Ratio of uAL to uCre, mg/g

522.0 ± 1533.1

1.1 (−24.9, 677.3)

−24.1 ± 350.4

−4.7 (−82.3, 11.7)

.322
Log, ratio of uTP to uCre

0.37 ± 1.01

0.15 (−0.15, 1.00)

−0.06 ± 0.77

−0.14 (−0.65, 0.47)

.170
Log, ratio of uAL to uCre

0.14 ± 1.19

0.08 (−0.55, 0.63)

−0.05 ± 1.12

−0.26 (−0.75, 0.92)

.594

Note: Study group = group 1; control group = group 2.

Abbreviations: Ccr, creatinine clearance rate; BUN, blood urine nitrogen; Log, logarithmized; uAL, urine albumin; uCre, urine creatinine; uTP, urine total protein.